(Q38193616)

30 August 2017

Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis (English)

1 reference

cardiovascular abnormality

30 August 2017

1 reference

Shan-Miao Lin

1

1 reference

30 August 2017

Hsiang-Yu Lin

2

1 reference

30 August 2017

Chih-Kuang Chuang

3

1 reference

30 August 2017

Shuan-Pei Lin

4

1 reference

30 August 2017

Ming-Ren Chen

5

1 reference

30 August 2017

21 February 2014

1 reference

Molecular Genetics and Metabolism

30 August 2017

1 reference

30 August 2017

111

1 reference

30 August 2017

4

1 reference

30 August 2017

493-498

1 reference

Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI.

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Echocardiographic study of paediatric patients with mucopolysaccharidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Differences in left ventricular ejection fraction using teichholz formula and volumetric methods by cmr: implications for patient stratification and selection of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Interventricular septal thickness and left ventricular hypertrophy. An echocardiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Longitudinal data analyses using linear mixed models in SPSS: concepts, procedures and illustrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--clinical and echocardiographic findings in 64 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Cardiovascular changes in mucopolysaccharidoses in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Sudden death in Hunter syndrome caused by complete atrioventricular block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Management guidelines for mucopolysaccharidosis VI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

Mucopolysaccharidosis I: management and treatment guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.02.009

10.1016/J.YMGME.2014.02.009

7 January 2021

Identifiers

DOI

1 reference

30 August 2017

1 reference